drugset

drugset / Trial / NCT00676780

Green Tea Extract and Prostate Cancer

NCT00676780 ↗

Phase 2 Completed 33 enrolled Louisiana State University Health Sciences Center Shreveport Polyphenon Pharma · collab

NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to see if a green tea extract can beneficially alter several markers of cancer risk and progression.

Timeline

Start: 2004-05
Primary completion: 2008-12
Completion: 2008-12

Publications

Results McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila). 2009 Jul;2(7):673-82. doi: 10.1158/1940-6207.CAPR-08-0167. Epub 2009 Jun 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sinecatechins	Unknown	800 mg	—

Indications